- As tipped Wednesday, Japanese drugmaker Otsuka Holdings (OTCPK:OTSKF) is set to buy Astex Pharmaceuticals (NASDAQ:ASTX) for around $886M in the largest deal for the Tokyo-based company since it snapped up a 49% stake in a French mineral water bottler five years ago.
- Otsuka expects to launch a tender offer at $8.50/ share "within 10 business days."
- The deal increases the profile of Otsuka's oncology business and strengthens its pipeline as it prepares for patent expiration on Abilify.
- See also: ASTX reports topline results for SGI-110 in AML patients, Feuerstein skeptical
Otsuka to buy Astex in $886M deal
Recommended For You
More Trending News
About OTSKF Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
OTSKF | - | - |
Otsuka Holdings Co., Ltd. |